Key facts
- It has raised $1.1M; the latest was Accelerator/Incubator in Jan 2026.
- Notable investors include Draper Associates, MassRobotics, Ascender (Pittsburgh), Merck Digital Sciences Studio.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Whelix
- ·The full record, as it builds
Funding rounds
No funding rounds for Whelix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Whelix
Developer of an AI-powered robotic system designed to automate research-scale cell culture. The company's software monitors and analyzes key cell metrics to determine when to pass cells, change media, and perform plating, among others, while controlling the robotics to execute these actions, enabling researchers to automate functions to improve lab efficiency.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2023
- Employees
- 6
- Website
- whelix.co/
- Ownership
- Privately Held (backing)
Whelix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Whelix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Whelix in its N-PORT filings yet. We sweep new filings monthly.